Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Chen Xia
Central South University - Department of Pharmacy
China
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
56
TOTAL CITATIONS
4
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Landscape of Next Generation Sequencing in Screening Accurate Benefit Population for First Line Crizotinib in ALK Rearranged Advanced Non-Small Cell Lung Cancer
Number of pages: 21
Posted: 24 Jan 2019
Liang Zeng
,
Chunhua Zhou
,
Yizhi Li
,
Lin Wu
, Chen Xia,
Wenjuan Jiang
,
Yijuan Hu
,
Dehua Liao
,
Lili Xiao
,
Li Liu
,
Haiyan Yang
,
Yi Xiong
,
Rui Guan
,
Yongchang Zhang
and
Nong Yang
Central South University - Department of Medical Oncology, Central South University - Department of Medical Oncology, Central South University - Department of Medical Oncology, Central South University - Department of Medical Oncology, Second Chest Cancer Unit, Central South University - Department of Pharmacy, Central South University - Department of Medical Oncology, Central South University - Department of Medical Oncology, Central South University - Department of Pharmacy, Central South University - Department of Medical Oncology, Central South University - Department of Medical Oncology, Central South University - Department of Medical Oncology, Central South University - Department of Medical Oncology, Central South University - Department of Medical Oncology, Central South University - Department of Medical Oncology and Central South University - Department of Medical Oncology
Downloads
56
(1,000,027)
Citation
4
View PDF
Download
Abstract:
NGS, Ventana, ALK, Fusion partners, Crizotinib
Feedback